• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Regulatory

Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.

Posted inDrug Safety, Metabolism, Regulatory

Febuxostat in Treatment of Gout: Walk With Death

by Julia Mardi April 7, 2021September 8, 2022

A popular antigout drug Uloric carries increased risks of death.

Liver.
Posted inMetabolism, New Drugs, Regulatory

Lipaglyn: World’s First Drug to Treat Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

by Tanya von Reuss and Timur Burkhanayev April 6, 2021September 8, 2022

Saroglitazar by Zydus Cadila has opened the doors to a new multi-billion dollar sector of NASH and NAFLD pharmacological treatments.

Insomnia.
Posted inNeuroscience, New Drugs, Regulatory

Dayvigo: New Japanese Drug for Insomnia

by Mark Gubar April 4, 2021September 8, 2022

Lemborexant by Eisai to help you fall asleep. Chronic sleep loss, go away!

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

by Tanya von Reuss and Timur Burkhanayev April 3, 2021September 8, 2022

A deadly disease and modern pharmacological attempts to treat it.

Suicide.
Posted inDrug Safety, Regulatory

Montelukast Drives Patients to Suicide

by Julia Mardi April 1, 2021September 8, 2022

A popular asthma and allergy drug Singulair can make you lose your mind.

Multiple sclerosis.
Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory

Mayzent: New Drug for Treatment of Secondary Progressive Multiple Sclerosis

by Tanya von Reuss April 1, 2021September 8, 2022

Siponimod released by Novartis is an improved version of Gilenya.

Posted inNew Drugs, Oncology, Regulatory

Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer

by Mark Gubar March 31, 2021September 8, 2022

Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.

Posts pagination

Newer posts 1 … 11 12 13 14 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×